HLA-DRB1 and multiple sclerosis in Malta

Neurology

Volumn 70, Issue 2, 2008, Pages 101-105

  Dean, G ^a,i   Yeo, T W ^b   Goris, A ^b,c   Taylor, C J ^d   Goodman, R S ^d   Elian, M ^e   Galea Debono, A ^f   Aquilina, A ^g   Felice, A ^h   Vella, M ^f   Sawcer, S ^b   Compston, D A S ^b  

^a HEALTH RESEARCH BOARD   (Ireland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^f ST LUKE S HOSPITAL   (Malta)

^g Maltese Blood Transfusion Service   (Malta)

^h UNIVERSITY OF MALTA   (Malta)

ⁱ NONE   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALTA; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL;

EID: 37849008962     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000284598.98525.d7     Document Type: Article

References (31)

1. Dean G, McLoughlin H, Brady R, Adelstein AM, Tallett-Williams J. Multiple sclerosis among immigrants in Greater London. BMJ 1976;1:861-864.
2. Dean G, Brady R, McLoughlin H, Elian M, Adelstein AM. Motor neurone disease and multiple sclerosis among immigrants to Britain. Br J Prev Soc Med 1977;31:141-147.
3. Vassallo L, Elian M, Dean G. Multiple sclerosis in southern Europe: II. Prevalence in Malta in 1978. J Epidemiol Community Health 1979;33:111-113.
4. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
5. Dean G, Elian M, de Bono AG, et al. Multiple sclerosis in Malta in 1999: an update. J Neurol Neurosurg Psychiatry 2002;73:256-260.
6. Grimaldi LM, Salemi G, Grimaldi G, et al. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology 2001;57:1891-1893.
7. Grimaldi L, Palmeri B, Salemi G, et al. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology 2007;28:28-32.
8. Savettieri G, Salemi G, Rogonese P, et al. Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy. J Neurol 1998;245:40-43.
9. Dean G, Savettieri G, Giordano D, et al. The prevalence of multiple sclerosis in Sicily: II. Agrigento City. J Epidemiol Community Health 1981;35:118-122.
10. Nicoletti A, Lo Bartolo ML, Lo Fermo S, et al. Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology 2001;56:62-66.
11. Compston A, Confavreux C, Lassmann H, et al.. McAlpine's multiple sclerosis. 4th ed. London: Churchill Livingstone, 2006.
12. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005;14:2019-2026.
13. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998;7:1235-1237.
14. Brassat D, Salemi G, Barcellos LF, et al. The HLA locus and multiple sclerosis in Sicily. Neurology 2005;64:361-363.
15. Elian M, Alonso A, Awad J, et al. HLA associations with multiple sclerosis in Sicily and Malta. Dis Markers 1987;5:89-99.
16. Koch-Henriksen N. Multiple sclerosis in Malta in 1999. J Neurol Neurosurg Psychiatry 2002;73:239-240.
17. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-235.
18. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005;21:3445-3447.
19. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003;25:115-121.
20. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995;57:487-498.
21. Garcia JR, Rodriguez S, Sosa Henriquez M, et al. Prevalence of multiple sclerosis in Lanzarote (Canary Islands). Neurology 1989;39:265-267.
22. Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A. Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls. Eur J Immunogenet 1995;22:443-465.
23. Milanov I, Georgiev D, Kmetska K, Jordanova L, Topalov N. Prevalence of multiple sclerosis in Bulgaria. Neuroepidemiology 1997;16:304-307.
24. Coraddu F, Reyes-Yanez MP, Parra A, et al. HLA associations with multiple sclerosis in the Canary Islands. J Neuroimmunol 1998;87:130-135.
25. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-191.
26. Harbo HF, Lie BA, Sawcer S, et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004;63:237-247.
27. Spinola H, Middleton D, Brehm A. HLA genes in Portugal inferred from sequence-based typing: in the crossroad between Europe and Africa. Tissue Antigens 2005;66:26-36.
28. Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 2003;61:403-407.
29. Capelli C, Redhead N, Romano V, et al. Population structure in the Mediterranean basin: a Y chromosome perspective. Ann Hum Genet 2006;70:207-225.
30. Granieri E, Tola R, Paolino E, Rosati G, Carreras M, Monetti VC. The frequency of multiple sclerosis in Italy: a descriptive study in Ferrara. Ann Neurol 1985;17:80-84.
31. Morganti G, Naccarato S, Elian M, et al. Multiple sclerosis in the Republic of San Marino. J Epidemiol Community Health 1984;38:23-28.